Increasing Prevalence of Chronic Diseases to Augment Growth of the Generic Sterile Injectable Market
The generic sterile injectables are (Food and Drug Administration-approved) biologics that are used for the treatment of various drugs and have the same active ingredients as its branded versions. However, the inactive content of the drug may vary. The generic sterile injectables are widely used in majority of clinics and hospitals worldwide. However, these Injectables are very inexpensive compared to their branded counterparts. Market Dynamics: Increasing prevalence of chronic diseases, especially in North America, is expected to augment the growth of the generic sterile injectable market. According to the Centers for Disease Control and Prevention (CDC), chronic diseases such as diabetes, cancer, and heart disease are the leading causes of death and disability in the United States. Moreover, the outbreak COVID-19 is expected to offer lucrative growth opportunities for players in the generic sterile injectable market. For instance, in January 2021, Civica planned to build a...